Generic Lucemyra is indicated for symptoms associated with acute withdrawal from opioids and for facilitation of the completion of opioid discontinuation treatment.
Brimonidine Tartrate Ophthalmic Solution, 0.1%, is indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.
Betamethasone valerate foam is indicated for relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses of the scalp.